×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Gold Loan
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Eco Pulse
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2
26
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Dewas
Dewas
Sun Pharma issues profit warning for FY16
Sun Pharma up 2%; CLSA ups target, Mohali resolution key
Ranbaxy loses approvals, exclusivity of 2 drugs in US
EU bans imports from Ranbaxy's antibiotic injectables unit
Ranbaxy falls 4% post drug recall in US
Rupee goof up: RBI prints notes with Subbarao's signature
Ranbaxy suspends drug ingredients shipment from two plants
Ranbaxy may post Q3 PAT at Rs 10 cr, guidance revision key
Mumbai airport new int'l terminal to start in Jan: GVK
Checkout: Contradictory view of brokerages on Ranbaxy
DCGI finds minor deficiencies in Ranbaxy inspection: Srcs
Adulterated drugs: SC dismisses PIL against Ranbaxy
Ranbaxy shrs fall on USD 500mn US lawsuits settlement
Ranbaxy puts past to rest, bright future ahead: Macquarie
Ranbaxy US settlement positive, but penalty high: Analysts
Ranbaxy's roller coaster ride on settlement with US FDA
Ranbaxy falls as US settlement provision to hurt earnings
USFDA approval of plant a shot in the arm for Ranbaxy
Ranbaxy falls on uncertainties over generic Lipitor launch
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio